Conceptio › Archive › NCBI PubMed Central
NCBI PubMed Centralopen access

Virtual screening identifies specnuezhenide as a potential therapeutic agent for rosacea via KLK5/TLR4/NF-κB pathway inhibition and metabolic modulation.

Xu J et al.
NCBI PubMed Central · Papers · License: Open Access
Open Source ↗Direct PDF ↓
computerscienceeducation
computer science education
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 452974
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.